Pembrolizumab as first-line treatment for non-small cell lung cancer-a game changer?
Department of Medical Oncology, Kyowa Kirin Pharmaceutical Development Ltd., Galashiels, UK;; Department of Haematology and Oncology, University Hospital of Grosshadern, University of Munich, Munich, Germany.
Wolfram C M
WC
Dempke
Department of Medical, Medical School Hamburg (MSH), Hamburg, Germany.
Klaus
K
Fenchel